Processa Pharmaceuticals Inc (NASDAQ:PCSA) traded at $0.28 at close of the session on Monday, June 23 and made a downward move of -14.09%% on its previous day’s price.
Looking at the stock we see that its previous close was $0.32 and the beta (5Y monthly) reads 1.372 with the day’s price range being $0.255 – $0.3096. In terms of its 52-week price range, PCSA has a high of $3.10 and a low of $0.15. The company’s stock has gained about 14.06% over that past 30 days.
Processa Pharmaceuticals Inc has a market cap of $7.20 million and is expected to release its quarterly earnings report on 2025-May-08.
On the other hand, looking at the outlook for the PCSA stock, short term indicators assign the stock an average of 50% Sell, while medium term indicators assign it an average of 50% Sell.
Based on estimates by 2 analysts, where scores have ranged from 1.00 for a strong buy to 5.00 for a strong sell, 0 have rated the Processa Pharmaceuticals Inc (PCSA) stock as a Hold, while 2 rate it as a Buy. 0 analyst(s) rate it as overweight while 0 of them rated it as underweight, whereas 0 suggest the stock as a Sell. The stock has an overall rating of Buy and investors could take advantage and scoop up stock of the company.
Looking further, we note the current price level is -6.47% off its SMA20 and 4.22% from its 50-day simple moving average. The RSI (14) is pointing at 48.68 while the volatility over the past week is 19.76% and jumps to 12.97% over the past one month. The average price target for the stock over the next 12 months is $9, with the estimates having a low of $9 and a high of $9. These price ends are -3114.29% and -3114.29% off the current price level respectively, although investors could be excited at the prospect of a -3114.29% if the PCSA share price touches on the median price of $9.
Coming back to Processa Pharmaceuticals Inc (NASDAQ:PCSA), we note that the average 3-month trading volume was 16.77 million, while that of the preceding 10-day period stands at 81.87 million. Current shares outstanding are 26.19 million.
The insiders hold 12.12% of the company’s shares while institutions hold 0.65%. The data shows that short shares as of 2025-05-30, stood at 0.75 million at a short ratio of 0.26. This represents a 663.00 short interest in shares outstanding on 2025-05-30. Shares short rose in May from the previous month at 70227.0. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock -84.97% down in year-to-date price movement.
